It ain't hitting 70 cents on UK approval alone. At best 30 or 40 cents depending on when the approval comes. We need lots of bag holders to not sell and maybe purchase more shares at UK approval so that a few others that want out can exit at the best price on UK approval spike.
The only good news that matters at this stage is significant non dilutive funding from big pharma. Everything else including Oncovir partnership and other such fluff PRs will be another opportunity for shorts to slam the stock. So it will be back to 20 cents or less in no time.
One can argue just as easily that if the SP hits 70¢ it is because approval has happened and probably some other good news. If that is the case many will choose to hold on and see if the company continues to make real progres
I agree that if the news is approval + large nondilutive financing that most retailers will not sell for they will simply conclude that NWBO's days of dilution are behind us. The subject was just approval thats it.